MaRS Innovation specializes in extreme early-stage seed investing for companies and technology emerging from our 15 members.

Case Studies
Curious about MI’s impact? Visit our gallery to learn about a few of the technologies we’ve been proud to accelerate.
Learn More
Our Members
MI’s portfolio draws from three universities, nine teaching hospitals and two research institutes. Learn more about our members.
Learn More
Work With Us
Through our member-exclusive funding programs and services, MI works with founders to bring their technology to market faster.
Learn More
Recent News

Encycle Therapeutics announces discovery collaboration with Pfizer Inc.

TORONTO, November 1, 2017 – Encycle Therapeutics (“Encycle”), a Toronto-based drug discovery company built on a unique chemistry that enables the synthesis of a new type of constrained peptide called “nacellins,” today announced a …

LAB150 – Strategic Partnership with Evotec AG

Toronto, Sept. 14, 2017 (GLOBE NEWSWIRE) — MaRS Innovation (“MI”) and Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced the launch of “LAB150”.  This transformational Toronto-based partnership will give Canada access …

Ministry of Health and Long Term Care selects BresoTec for Sleep Apnea Test Project

Toronto, Canada, May 16, 2017 – BresoDx®, developed by BresoTec, has been selected by the Ministry of Health and Long-Term Care (MOHLTC) for use in a home-based sleep apnea demonstration project with sleep clinics across …

MaRS Innovation shifted my perspective from BlueDot's research to its potential as a global business. They worked with me to incorporate the company, develop a business plan and model suitable for a social enterprise, and hire key talent, while supporting me through BlueDot’s early stages of growth and development.
Kamran Khan, MD, MPH
Founder / BlueDot
MaRS Innovation is doing some great things with great people. The honest war stories from seasoned entrepreneurs, tough love from advisors and direct support from people on the team are a rare find. MI and UTEST are and continue to be the reasons we're thriving as a business.
Marissa Wu
Co-Founder / Onyx Motion
MaRS Innovation understood the value of my invention and saw its potential when others didn’t (they’re starting to now!). I’m grateful for the investment and mentoring I received through the UTEST program.
James Colliander, PhD
Co-Founder / Crowdmark
The UTEST program and MaRS Innovation have been fantastic for TrendMD; we would not be where we are today without them. Both from a strategic and financial perspective, UTEST definitely served as the initial spark that was crucial for getting us off the ground.
Paul Kudlow, MD
Founder / TrendMD
MaRS Innovation’s unique ecosystem allows innovators and researchers to keep the high impact of their innovation while enabling it with frameworks for commercialization. Their dedicated expert team allowed us to launch, structure and scale our company both in Canada and in the rest of the world while allowing us to maintain our research and academic mandates.
Hossein Rahnama, PhD
Founder / Flybits
There is nothing more powerful I can say than the simple fact that we would not even exist as a company were it not for the UTEST program.
William Walmsley
Co-Founder / Whirlscape
MaRS Innovation was a vital partner as we refined our technology, our business model and our go-to-market strategy. Without their support, and the support of UTEST, we would not be in the position we are today.
Craig Boutilier, PhD
Co-Founder / Granata Decision Systems
The guidance and resources that Mars Innovation has provided significantly excelled Nvest forward. We have appeared on major newspapers, formed important relationships with strategic partners, and developed stronger user acquisition strategy. Our progress and success to date and trajectory going forward could not have been achieved without the combined help of MaRS Innovation and UTEST.
Fredrick Zhou
Co-Founder / NVest